Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Forms Assay Collaboration with BioLegend

NEW YORK (GenomeWeb News) – PerkinElmer said today that it has struck an assay development and sample testing collaboration with immunological reagents developer BioLegend.

The agreement will enable BioLegend to offer immunoassay development and bioanalytical testing based on PerkinElmer's AlphaLISA assay technology.

The homogenous, bead-based PerkinElmer technology is comprised of quantitative assays with ranges that are broader than standard enzyme-linked immunosorbent assays, and the company said it can save time in lab workflows and can eliminate wash steps that are difficult to automate. PerkinElmer also said that the technology allows for easy integration into automated high-throughput testing systems, such as its JANUS liquid handling system.

"Combining PerkinElmer's technologies with BioLegend's unique immunoassay development capabilities enables scientists to benefit from reduced barriers to discovery such as time or resource constraints," PerkinElmer's Bio-discovery President, Richard Eglen, said in a statement.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.